Loading BioAtlas...
Loading BioAtlas...
Should you run AlphaFold 3 or deploy a Protein Language Model like ESM-3 or ESM-2? A decisive guide to structural predictors versus generative sequence models in 2026, comparing compute footprints, input modalities, and real biological task fit.
Side-by-side evaluation of capabilities, hardware sizing, and commercial eligibility.
| Tool | Architecture Type | Key Biological Capability | Input Requirements | Hardware Footprint | Licensing & Access | Best Primary Use Case |
|---|---|---|---|---|---|---|
| AlphaFold 3 ↗ | Evoformer / Pairformer Diffusion | Joint complex prediction (Protein + DNA/RNA + Ligands + PTMs) | FASTA + Ligand SMILES / CCD + PTM IDs + MSA | 1x NVIDIA A100 (80GB) or AF Server | Public weights (Academic / Non-commercial) | Accurate 3D co-folding & multi-chain binding poses |
| ESM-3 (98B / 1.4B) ↗ | Multimodal Generative Transformer (Sequence + Structure + Function) | De novo protein generation, simultaneous multi-track reasoning | Partial sequence, coordinates, or InterPro functional tags | 1x A100 for 1.4B; multi-node cluster / AWS API for 98B | Commercial API + Open 1.4B weights (Non-commercial) | De novo protein design with specific catalytic motifs |
| Chai-1 ↗ | Multi-modal Diffusion Foundation Model | Single-sequence structural prediction without requiring deep MSAs | FASTA sequences + SMILES / chemical structures | 1x NVIDIA RTX 4090 (24GB) or A100 | Commercial use permitted via web / weights (Academic) | Orphan proteins, antibody-antigen without deep MSAs |
| RoseTTAFold All-Atom ↗ | 3-Track Neural Network (Sequence + Residue + Atom) | Biological assemblies including non-protein covalent modifications | FASTA sequence + chemical structure files + MSA | 1x NVIDIA A100 / RTX 3090 (24GB) | Open Source (Academic Non-Commercial) | Covalent inhibitor design & protein-nucleic acid complexes |
No computational biology model is universal. Understand where accuracy degrades and where hidden operational costs emerge before committing pipeline infrastructure.
AlphaFold 3 and RoseTTAFold All-Atom rely heavily on deep evolutionary profiles (MSAs) generated via Jackhmmer or MMseqs2. For orphan proteins, de novo designed scaffolds, or rapidly mutating viral strains, MSA construction can take 10x longer than neural inference and degrade accuracy.
While diffusion-based predictors excel at rigid protein backbones, unconstrained small-molecule docking within AlphaFold 3 or Chai-1 can occasionally produce clashing bond angles or unphysical torsions that require downstream molecular mechanics relaxation (e.g., OpenMM or Amber).
Running 98B-parameter generative models like ESM-3 locally requires enterprise multi-GPU nodes (8x H100 80GB) with high-bandwidth interconnects (NVLink). Small labs must rely on commercial cloud APIs, introducing data privacy and per-inference token costs.
Selecting the wrong tool for an ill-suited biological objective leads to wasted GPU hours and non-reproducible wet-lab experiments. Follow these hard anti-pattern guardrails:
Do NOT choose AlphaFold 3 if you need to screen millions of sequences in high-throughput (use ESM-2 or ProteinMPNN instead), or if your workflow requires unrestricted commercial commercialization of predicted models without IP encumbrance.
Do NOT choose pure sequence language models if your immediate experimental question depends on sub-angstrom atomic coordinates, metal-ion coordination geometries, or explicit stereochemical ligand binding affinity.
Do NOT choose complex all-atom predictors if you only have CPU compute available. Running local inference on CPUs will result in memory out-of-core errors and multi-hour runtimes.
在整个产品目录中探索完整的技术规范、基准测试分数、经过验证的许可条款和实时可用性。